Plasma dehydroepiandrosterone sulfate levels in patients with major depressive disorder correlate with remission during treatment with antidepressants

Human Psychopharmacology

Volumn 29, Issue 3, 2014, Pages 280-286

  Morita, Tokiko ^a,b   Senzaki, Koji ^b   Ishihara, Ryoko ^b   Umeda, Kazunori ^c   Iwata, Nakao ^c   Nagai, Taku ^b   Hida, Hirotake ^a   Nabeshima, Toshitaka ^a   Yukawa, Kazunori ^a   Ozaki, Norio ^b   Noda, Yukihiro ^a,b  

^a MEIJO UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Absence of Depressive and Anxious Mood (ADAM) score; dehydroepiandrosterone sulfate (DHEA S); major depressive disorder; remission

Indexed keywords

ANTIDEPRESSANT AGENT; PRASTERONE SULFATE;

ADULT; BLOOD; BLOOD ANALYSIS; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMAN; MALE; MIDDLE AGED; PROCEDURES; PSYCHOLOGICAL RATING SCALE; RADIOIMMUNOASSAY; REMISSION; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; ANTIDEPRESSIVE AGENTS; BLOOD CHEMICAL ANALYSIS; DEHYDROEPIANDROSTERONE SULFATE; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RADIOIMMUNOASSAY; REMISSION INDUCTION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84898804135     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.2400     Document Type: Article

References (38)

1. Baulieu EE,. 1981. Steroid hormones in the brain: several mechanisms. In Steroid Hormone regulation of the brain, Fuxe K, Gustafson JA, Wetterberg L, (eds). Pergamon: NY; 3-14.
2. Baulieu EE,. 1998. Neurosteroids: a novel function of the brain. Psychoneuroendocrinology 23: 963-987.
3. Baulieu EE, Robel P,. 1996. Dehydroepiandrosterone and dehydroepiandrosterone sulfate as neuroactive neurosteroids. J Endocrinol 150: S221-239.
4. Bergeron R, de Montigny C, Debonnel G,. 1996. Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors. J Neurosci 16: 1193-1202.
5. Bermack JE, Debonnel G,. 2005. The role of sigma receptors in depression. J Pharmacol Sci 97: 317-336.
6. Bloch M, Schmidt PJ, Danaceau MA, Adams LF, Rubinow DR,. 1999. Dehydroepiandrosterone treatment of midlife dysthymia. Biol Psychiatry 45: 1533-1541.
7. 1 receptor ligands. Curr Neuropharmacol 6: 344-366.
8. 1) receptors in modulating the anti-depressant effect of neurosteroids (dehydroepiandrosterone or pregnenolone) in mouse tail-suspension test. J Psychopharmacol 22: 691-696.
9. Fabian TJ, Dew MA, Pollock BG, et al,. 2001. Endogenous concentrations of DHEA and DHEA-S decrease with remission of depression in older adults. Biol Psychiatry 50: 767-774.
10. Garrone B, Magnani M, Pinza M, Polenzani L,. 2000. Effects of trazodone on neurotransmitter release from rat mossy fibre cerebellar synaptosomes. Eur J Pharmacol 400: 35-41.
11. Hashimoto K,. 2009. Sigma-1 receptors and selective serotonin reuptake inhibitors: clinical implications of their relationship. Cent Nerv Syst Agents Med Chem 9: 197-204.
12. Hsiao CC,. 2006a. Difference in pre- and post-treatment plasma DHEA levels were significantly and positively correlated with difference in pre- and post-treatment Hamilton depression scores following successful therapy for major depression. Psychoneuroendocrinology 31: 839-846.
13. Hsiao CC,. 2006b. Positive correlation between anxiety severity and plasma levels of dehydroepiandrosterone sulfate in medication-free patients experiencing a major episode of depression. Psychiatry Clin Neurosci 60: 746-750.
14. Imamura M, Prasad C,. 1998. Modulation of GABA-gated chloride ion influx in the brain by dehydroepiandrosterone and its metabolites. Biochem Biophys Res Commun 243: 771-775.
15. Izawa S, Sugaya N, Shirotsuki K, et al,. 2008. Salivary dehydroepiandrosterone secretion in response to acute psychosocial stress and its correlations with biological and psychological changes. Biol Psychol 79: 294-298.
16. A receptor. Brain Res 526: 143-146.
17. Maurice T, Gregoire C, Espallergues J,. 2006. Neuro(active)steroids actions at the neuromodulatory sigma1 (sigma1) receptor: biochemical and physiological evidences, consequences in neuroprotection. Pharmacol Biochem Behav 84: 581-597.
18. 1) receptor: pharmacological evidence and therapeutic opportunities. Jpn J Pharmacol (J Pharmacol Sci) 81: 125-155.
19. 1 receptors in the mouse forebrain. J Neurosci Res 46: 734-743.
20. Maurice T, Su TP,. 2009. The pharmacology of sigma-1 receptors. Pharmacol Ther 124: 195-206.
21. 3H] norepinephrine release evoked by N-methyl- d -aspartate in the rat hippocampus. Proc Natl Acad Sci U S A 92: 3774-3778.
22. Narita N, Hashimoto K, Tomitaka S, Minabe Y,. 1996. Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain. Eur J Pharmacol 307: 117-119.
23. Ohashi M, Kato K, Nawata H, Ibayashi H,. 1986. Adrenocortical responsiveness to graded ACTH infusions in normal young and elderly human subjects. Gerontology 32: 43-51.
24. Paslakis G, Luppa P, Gilles M, et al,. 2010. Venlafaxine and mirtazapine treatment lowers serum concentrations of dehydroepiandrosterone-sulfate in depressed patients remitting during the course of treatment. J Psychiatr Res 44: 556-560.
25. Rupprecht R,. 1997. The neuropsychopharmacological potential of neuroactive steroids. J Psychiatr Res 31: 297-314.
26. Rupprecht R,. 2003. Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties. Psychoneuroendocrinology 28: 139-168.
27. Schmidt PJ, Daly RC, Bloch M, et al,. 2005. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression. Arch Gen Psychiatry 62: 154-162.
28. Schüle C, Baghai TC, Eser D, Schwarz M, Bondy B, Rupprecht R,. 2009. Effects of mirtazapine on dehydroepiandrosterone-sulfate and cortisol plasma concentrations in depressed patients. J Psychiatr Res 43: 538-545.
29. Schüle C, Nothdurfter C, Rupprecht R,. 2014. The role of allopregnanolone in depression and anxiety. Prog Neurobiol 113: 79-87.
30. Silverstone PH, Entsuah R, Hackett D,. 2002. Two items on the Hamilton Depression rating scale are effective predictors of remission: comparison of selective serotonin reuptake inhibitors with the combined serotonin/ norepinephrine reuptake inhibitor, venlafaxine. Int Clin Psychopharmacol 7: 273-280.
31. Skuza G,. 2003. Potential antidepressant activity of sigma ligands. Pol J Pharmacol 55: 923-934.
32. Takebayashi M, Kagaya A, Uchitomi Y, et al,. 1998. Plasma dehydroepiandrosterone sulfate in unipolar major depression. J Neural Transm 105: 537-542.
33. Tollefson GD, Haus E, Garvey KJ, Evans M, Tuason VB,. 1990. 24 hour urinary dehydroepiandrosterone sulfate in unipolar depression treated with cognitive and/or pharmachotherapy. Ann Clin Psychiatry 2: 39-45.
34. Volz HP, Stoll KD,. 2004. Clinical trials with sigma ligands. Pharmacopsychiatry 37 (Suppl 3): S214-220.
35. Webb SJ, Geoghegan TE, Prough RA, Michael Miller KK,. 2006. The biological actions of dehydroepiandrosterone involves multiple receptors. Drug Metab Rev 38: 89-116.
36. Werling LL, Keller A, Frank JG, Nuwayhid SJ,. 2007. A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: treatment of involuntary emotional expression disorder. Exp Neurol 207: 248-257.
37. Wolkowitz OM, Reus VI, Roberts E, et al,. 1997. Dehydroepiandrosterone (DHEA) treatment of depression. Biol Psychiatry 41: 311-318.
38. Wolkowitz OM, Reus VI, Keebler A, Nelson N, Friedland M, Brizendine L, Roberts E,. 1999. Double-blind treatment of major depression with dehydroepiandrosterone. Am J Psychiatry 156: 646-649.